Intermittent Androgen Deprivation in Prostate Cancer: Are We Ready to Quit?

J Clin Oncol. 2016 Jan 20;34(3):211-4. doi: 10.1200/JCO.2015.64.1019. Epub 2015 Nov 30.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Androgen Antagonists / administration & dosage*
  • Antineoplastic Agents, Hormonal / administration & dosage*
  • Clinical Trials, Phase III as Topic / methods*
  • Humans
  • Male
  • Prostatic Neoplasms / drug therapy*
  • Randomized Controlled Trials as Topic / methods*

Substances

  • Androgen Antagonists
  • Antineoplastic Agents, Hormonal